RESUMEN
Fate of lentinan, which is one of antitumor polysaccharides, was investigated with 3H-lentinan. 3H-lentinan was prepared by Wilzbach 3H gas exposure labeling, then purified by the gel filtration chromatography. 1) After a single intravenous injection of 3H-lentinan, radioactivity in plasma declined in a biphasic process. 2) There were urinary and fecal excretion, but expiratory excretion was a small proportion. 3) The radioactivity was predominantly incorporated into the liver and spleen, indicating selective retention of the lentinan in reticuloendothelial system cells. On the other hand the level of radioactivity in the lung and kidneys was dropped rapidly. 4) We can not find the selective incorporation of radioactivity into the tumor. 5) There was no species difference on the distribution of lentinan among mouse, rat and dog. 6) These results obtained were similar to other polysaccharides and immunologic antitumor agents.
Asunto(s)
Lentinano/metabolismo , Polisacáridos/metabolismo , Animales , Perros , Ratones , Ratas , Especificidad de la Especie , Factores de Tiempo , Distribución Tisular , TritioRESUMEN
3H-labeled lentinan was prepared by methylation with 3H-dimethyl-sulfate. Blood level, distribution and excretion were studied in rats. After intravenous injection of [methyl-3H] -methyl lentinan, radioactivity rapidly disappeared from blood, lung and kidney, distributed mainly in liver, spleen and mesenteric lymph nodes. There was urinary excretion, but expiratory excretion was a small proportion. In the case of multi-injection of [methyl-3H] -methyl lentinan distribution of radioactivity was similar to a single injection, but retention of 3H was less than a single injection. Bile excretion and transport to fetuses and milk were in mere trace amounts. No substantial difference was found between two types of the 3H-labeled lentinan in either the distribution or excretion.